Company Search:
Advanced Search
Sponsored Links
Dottikon ES Holding AG Company Snapshot
Dottikon ES Holding AG operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dottikon ES Holding AG with three other pharmaceutical manufacturers in Europe: Advanced Medical Solutions Group plc of the United Kingdom (2017 sales of £96.91 million [US$135.35 million] ), Grindeks AS of Latvia (132.41 million Euro [US$164.08 million] ), and Alkaloid AD Skopje which is based in Macedonia (9.09 billion Denar [US$182.99 million] ).

Sales Analysis. During the year ended March of 2017, sales at Dottikon ES Holding AG were 151.75 million Swiss Francs (US$160.75 million). This is an increase of 25.0% versus 2016, when the company's sales were 121.43 million Swiss Francs. This was the fifth consecutive year of sales increases at Dottikon ES Holding AG (and since 2012, sales have increased a total of 87%). Sales of Fine Chemicals saw an increase of 42.7% in 2017, from 8.95 million Swiss Francs to 12.77 million Swiss Francs.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Dottikon ES Holding AG
  Stock Performance Chart for Dottikon ES Holding AG
  Stock Data: Recent Stock Performance:
  Current Price (3/9/2018): 710.00
(Figures in Swiss Francs)
1 Week -5.1%   13 Weeks -1.4%  
4 Weeks -12.1%   52 Weeks 14.5%  
Dottikon ES Holding AG Key Data:
  Ticker: DESN Country: Switzerland
  Exchanges: ZHR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 151,748,000
(Year Ending Jan 2018).
Employees: 544
  Currency: Swiss Francs Market Cap: 886,928,450
  Fiscal Yr Ends: March Shares Outstanding: 1,249,195
  Share Type: Namenaktie Closely Held Shares: 1,066,738
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.